Superselective transarterial chemoembolization (SSTACE) as second-line conversion therapy for locally advanced unresectable gastric or gastroesophageal junction adenocarcinoma: a preliminary retrospective cohort study
SSTACE could potentially offer a novel therapeutic approach for patients with locally advanced unresectable GC or GEJ cancer who have shown limited response to systemic chemotherapy/immunotherapy, characterized by SD or PD. This treatment may increase the likelihood of achieving surgical conversion and R0 resection rates while upholding a favorable safety profile.
Authors
- Yu Fu (ORCID: https://orcid.org/0009-0001-3829-4628)
- Qinyuan Wang
- Yufeng Qing (ORCID: https://orcid.org/0000-0001-6709-7570)
- Jingjing Chen (ORCID: https://orcid.org/0000-0001-6994-0074)
- Tianyi Wang (ORCID: https://orcid.org/0009-0009-1133-347X)
- Nelson Chen (ORCID: https://orcid.org/0000-0001-8537-4244)
- Heqing Huang (ORCID: https://orcid.org/0000-0002-6135-9901)
- Pengcheng Ye (ORCID: https://orcid.org/0000-0001-8716-6174)
- Shoujiang Wei (ORCID: https://orcid.org/0000-0003-2820-3726)
- Qijun Lv (ORCID: https://orcid.org/0009-0003-7018-4343)
- Wei Zhang (ORCID: https://orcid.org/0000-0002-5467-6263)
Institutions
- North Sichuan Medical University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Affiliated Hospital of North Sichuan Medical College (CN)
- Science and Technology Department of Sichuan Province (CN)
Publication Details
- Journal
- European journal of medical research
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1186/s40001-025-03306-8
- Citations
- 1
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Natural Science Foundation of Sichuan Province